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Kisspeptin activates Ankrd 26 gene 
expression in Migrating embryonic 
gnrh neurons
Tomoko Soga1 , Wei Ling Lim1 , Alan Soo-Beng Khoo2 and Ishwar S. Parhar1*
1 Brain Research Institute, School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia, 
2 Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, Kuala Lumpur, Malaysia
Kisspeptin, a newly discovered neuropeptide, regulates gonadotropin-releasing hormone 
(GnRH). Kisspeptins are a large RF-amide family of peptides. The kisspeptin coded by 
KiSS-1 gene is a 145-amino acid protein that is cleaved to C-terminal peptide kiss-
peptin-10. G-protein-coupled receptor 54 (GPR54) has been identified as a kisspeptin 
receptor, and it is expressed in GnRH neurons and in a variety of cancer cells. In this 
study, enhanced green fluorescent protein (EGFP) labeled GnRH cells with migratory 
properties, which express GPR54, served as a model to study the effects of kisspeptin 
on cell migration. We monitored EGFP–GnRH neuronal migration in brain slide culture 
of embryonic day 14 transgenic rat by live cell imaging system and studied the effects 
of kisspeptin-10 (1 nM) treatment for 36 h on GnRH migration. Furthermore, to deter-
mine kisspeptin-induced molecular pathways related with apoptosis and cytoskeletal 
changes during neuronal migration, we studied the expression levels of candidate genes 
in laser-captured EGFP–GnRH neurons by real-time PCR. We found that there was 
no change in the expression level of genes related to cell proliferation and apoptosis. 
The expression of ankyrin repeat domain-containing protein (ankrd) 26 in EGFP–GnRH 
neurons was upregulated by the exposure to kisspeptin. These studies suggest that 
ankrd 26 gene plays an unidentified role in regulating neuronal movement mediated 
by kisspeptin–GPR54 signaling, which could be a potential pathway to suppress cell 
migration.
Keywords: metastasis, cancer, cytoskeleton, preoptic area, reproduction, gPr54
inTrODUcTiOn
Kisspeptin is a newly discovered neuropeptide that controls the onset of puberty and stimulates 
gonadotropin-releasing hormone (GnRH) release from the preoptic area (POA). Kisspeptin encoded 
by KiSS-1 gene is a 145-amino acid peptide. The primary translation products are shorter, bio-
logically active cleavage neuropeptides, kisspeptin-54, -14, -13, -10 amino acid residues, which are 
endogenous ligands for G-protein-coupled receptor 54 (GPR54) (1–3). Kisspeptin–GPR54 signaling 
is coupled with Gq/11 (1, 2). Intracellular kisspeptin–GPR54 pathway activates Ca2+-dependent 
signals, such as Ca2+ mobilization and phosphorylated by mitogen-activated protein kinases (1). 
Kisspeptin synthesizing neurons are localized in the hypothalamus, but expression of kisspeptin and 
GPR54 is also found in various peripheral tissue, such as the placenta, pancreas, the testes (3–5), and 
notably, GPR54 is expressed in metastatic human cancer cell lines (6).
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Reproductive neuropeptide, GnRH stimulates the secretion 
of pituitary gonadotropins and activates release of gonadal 
hormones to control reproductive activity. Interestingly, GnRH 
neurons have a unique developmental process. Embryonic GnRH 
neurons have high degree of motility; they originate from the 
olfactory placodes and migrate into the POA, their final residing 
place in the brain of all vertebrates (7–10). In rats, GnRH neurons 
actively start to migrate from the olfactory placodes on embryonic 
day 13.5 (E13.5) (11) and reach their final position in the POA on 
E18−19 (12). Approximately 1500 GnRH neurons are observed 
during early developmental stages, and these remain unchanged 
in numbers in the POA during adult stages (11, 12). Abnormal 
development of GnRH neurons, such as failed embryonic migra-
tion, altered numbers or positioning in the POA causes hypogon-
adotropic hypogonadism and reproductive dysfunction (13, 14).
Although kisspeptin−GPR54 signaling in GnRH neurons is 
well demonstrated as a key component for the onset of puberty 
(15–18), GnRH neurons express GPR54 before pubertal onset 
and kisspeptin–GPR54 system are established in embryonic mice 
brain (19, 20). In addition, recent study suggests that neuronal 
connection of kisspeptin neurons in the arcuate nucleus and a 
specific subgroup of GnRH neurons are established during embry-
onic stage in mice brain (21). An important role in controlling 
reproduction is emblematic of kisspeptin’s biological functions 
(22); however, this peptide is multifunctional (5, 23). The peptide 
has been shown to regulate cognitive functions, such as anxiety, 
learning, and memory (24–26), and as a metastasis suppressor 
(Metastin = Kisspeptin 54) (2). There are no studies describing 
the function of kisspeptin–GPR54 cellular signaling in normal 
migrating GnRH cells in the developing brain. However, an earlier 
study had suggested the possibility of GPR54 as a “stop molecule” 
for GnRH neuronal migration in the brain of a teleost fish (27).
Several studies have shown that kisspeptin is involved in cancer 
cell invasion (28–30), cell migration (2–4, 6), cell cycle arrest, and 
induction of cancer cell apoptosis (31). The cellular mechanisms 
of kisspeptin’s inhibitory effect on cell invasion, migration, cell 
cycle arrest, or induction of apoptosis have been suggested to be 
via altered cell motility and adhesiveness (32).
As accumulating evidences of kisspeptin neurons and GPR54 
expression in early developmental stage, it is possible that kisspep-
tin–GRP54 signaling may be functionally involved in embryonic 
migrating GnRH neurons long before puberty and reproductive 
maturate stage. This study was designed to determine whether 
kisspeptin-10 could influence embryonic GnRH neuronal 
migration, which could be important in the understanding of the 
mechanisms of neuronal migration. Here, we report that kisspep-
tin-10 activates ankrd26 gene expression in migrating embryonic 
GnRH neurons and inhibits their ability to migrate.
MaTerials anD MeThODs
animals
Transgenic Wistar rats expressing the enhanced green fluorescent 
protein (EGFP) under control of the rat GnRH promoter (33) were 
used to enable the direct visualization of GnRH neurons. The rats 
were housed as groups (2−3/cage) under a 12-h light cycle (lights 
on from 12:00 a.m. to 12:00 p.m.) and controlled temperature 
(22.0 ± 1.0°C) in the Specific Pathogen Free animal facility of the 
Brain Research Institute, Monash University Malaysia. Food and 
water were available ad libitum. All procedures were carried out 
in accordance to the Guidelines for the Care and Use of Animals 
by Monash University (SOBSB/MY/2007/29, MARP/2011/064).
Dissection and Brain slice Preparation
Adult female rats were time-bred, with the presence of sperma-
tozoa in vaginal smear designated as on day 0 of gestation (E0). 
Pregnant female rats on E14 were anesthetized with an intraperi-
toneal injection of ketamine xylazine (4.5 mg/kg/body weight). 
The embryos were immediately removed from the uterus and 
placed on glass dish with cold 1× Krebs buffer (126 mM NaCl, 
2.5 mM KCl, 2.5 mM CaCl2 1.2 mM NaH2PO4, 1.2 mM MgCl2, 
25 mM NaHCO3, and 11 mM d-glucose, pH 7.2, sterile filtered). 
The embryonic brains were dissected in the cold Krebs buffer 
and embedded in 6.0% low gelling temperature agarose (Type 
VII-A, Sigma, St Louis, MO, USA) to harden on ice. The embed-
ded brains were trimmed, glued with cyanoacrlylate (Loctite 
404, Henkel Corporation, Rocky Hill, CT, USA) to the stage of 
vibratome (Vibratome 3000 Sectioning System, St. Louis, MO, 
USA), and sagittally sectioned at 300 μm thickness in cold Krebs 
buffer. The slices were collected into glass-bottom dish filled 
with Krebs buffer supplemented with HEPES buffer solution 
(GIBCO-Invitrogen, Carlsbad, CA, USA), gentamicin reagent 
solution (GIBCO-Invitrogen), and antibiotic-antimycotic solu-
tion (GIBCO-Invitrogen). All sections were then incubated in 
medium [DMEM/F12 Phenol Red Free (GIBCO-Invitrogen), 
B-27 serum-free supplement (GIBCO-Invitrogen), l-glutamate, 
antibiotic–antimycotic solution, l-glutamine (Sigma), and 
d-glucose (Sigma)]. The sections were viewed under inverted 
fluorescence microscope (Nikon TE2000, Japan) for selection of 
brain slices containing EGFP–GnRH neurons.
embryonic Brain slice culture
The embryonic brain slice selected for live cell imaging were 
adhered to the glass-bottom WillCo-dish (WillCo Wells BV, 
Amsterdam, Netherlands) using chicken plasma (10 μl; Sigma) 
with thrombin (25 μl; Sigma) (34) followed by 1.5 h incubation 
at 37°C. After incubation, 1  ml of culture medium [serum-
free Neurobasal medium (GIBCO-Invitrogen) supplemented 
with B27, l-glutamine, antibiotic–antimycotic solution, and 
d-glucose] was added into the dish. Slices were maintained in 
culture medium at 37°C, humidified with 5% CO2 for 3  h to 
allow the slices to adhere to the glass coverslip and acclimatize 
to the culture condition (35) before imaging. For the exposure 
to kisspeptin, E14 embryonic slices were maintained in culture 
medium for 12-h post plating and kisspeptin-10 [1 nM, KiSS-1 
(110–119) Amide, cat# 048-65, Phoenix Pharmaceuticals, Inc., 
Burlingame, CA, USA] was added twice at 12 h interval for static 
incubation. Imaging of embryonic EGFP–GnRH neurons was 
continued for an additional 12 h. Procedures for the brain slice 
culture and medium preparation were adapted from Bless et al. 
(36), with slight modifications to accommodate to the live cell 
imaging system.
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live cell imaging of embryonic  
egFP–gnrh neurons
The dish containing the attached E14 brain slice with culture 
medium was transferred into the chamber attached to the stage 
of Leica AF6000LX Live Cell Imaging System. The chamber 
temperature was maintained at 37°C, humidified with 5% CO2 
(PeCon GmbH, Erbach, Germany). EGFP–GnRH neurons were 
visualized and captured under the 20× objective lens of the 
inverted fluorescence microscope. Time-lapse image analysis 
of the EGFP–GnRH neurons from E14 (n =  6–13  cells/time 
point) were expressed as the total distance traveled (μm/12 h) 
and the average rate of movement (μm/h) at 12  h interval for 
36 h duration.
The exposure time, gain, and intensity parameters were kept 
constant during imaging A z-series of 25 images through the 
brain slice containing EGFP–GnRH neurons were collected 
every 4–5  μm interval (~100−125  μm), at 5  min interval for 
total 36 h of video microscopy. The z-series of images collected 
were processed using the analysis software (Leica LAS AF) into 
projected stacks, and video images were generated for the analysis 
of GnRH neuronal migration. The live cell image of GnRH migra-
tion was captured wildly throughout the olfactory bulbs, junction 
area and ventral forebrain in the sagittal slice culture. All data of 
GnRH migration were averaged in each anatomical area in E14 
developmental stage.
Video analysis
Due to the long-term observation of GnRH neurons, images of 
the EGFP–GnRH neurons were collected every 5 min interval for 
9, 12, or 15 h each session until 36 h of recording were completed. 
The video images were analyzed using Image Pro-Plus version 
6.0 (Media Cybernetics Incorporation, Bethesda, MD, USA) to 
track movement of EGFP–GnRH neurons for absolute distance 
and velocity across the recording period. The absolute distance 
is defined as the distance traveled by the neurons captured at 
each frame in the video image sequence. The velocity generated 
by the software was calculated by dividing the duration of each 
frame (5  min) in the video sequence by the absolute distance 
traveled. Data for the embryonic EGFP–GnRH neuron migration 
were presented as total distance traveled and the average rate of 
neuronal movement at 12 h interval. Data from the video images 
of EGFP–GnRH neurons that showed notable tissue movement 
were discarded.
real-Time Pcr for laser-captured single 
egFP–gnrh cell
After kisspeptin-10 treatment for 24 h (twice at 12 h interval), E14 
embryonic brain slices were washed in 0.1M phosphate buffered 
saline (PBS) and fixed in 4% paraformaldehyde (PFA) [buffered 
in 0.1M phosphate buffer (PB)]. The brain slices were re-cut in 
14  μm, were pasted on APS-coated slides (Fisher Scientific), 
and were washed in diethylpyrocarbonate-treated water for 20 s 
(5 s dips). The protocol used for laser capture single EGFP–GnRH 
and real-time PCR was as described previously (37). The tissues 
were dehydrated in an ethanol series (75% V/V, 95% V/V, and 
100%, 10 s each) and air dried. GnRH cells were dissected using a 
UV laser component of Arcturus Laser Capture Microdissection 
System (Arcturus, Mountain View, CA, USA) powered at 31%, 
slow speed cutting. The dissected cells (20–25 cells/animal) were 
pooled and collected into a microcentrifuge tube containing 
200 μl of chilled TBS using a micropipette attached to a micro-
manipulator (Narishige, Tokyo, Japan). The collected cells were 
precipitated by centrifugation at 3,000 rpm for 20 min at 4°C and 
the supernatant was discarded. The harvested cells were resus-
pended in 12.9 μl of lysis buffer solution [7.9 μl of DEPC-treated 
water, 1.2 μl of 10× first strand buffer, 1.2 μl of 40% NP40, 0.6 μl 
of Proteinase K (1 mg/ml), and 2 μl of glycogen (5 ng/ml)] and 
incubated at 50°C for 20 min, with mixing by vortexing at 10 min 
intervals. After inactivation of Proteinase K at 75°C, the lysate 
was treated with 0.5  μl of RQ1RNase-free DNase (Promega) 
at 37°C for 30 min. DNase was then inactivated with 1.0 μl of 
DNase stop solution (Promega) at 65°C for 10 min. For reverse 
transcription, 0.4 μl of DEPC-treated water, 0.8 μl of 10× first 
strand buffer (Applied Biosystems), 0.8  μl of 100  mM dNTP, 
2 μl of 10× random primers, 0.6 μl of RNase Inhibitor, and 1 μl 
of Multiscribe reverse transcriptase (Applied Biosystems) were 
added. The reaction solution was incubated at 25°C for 10 min, 
37°C for 2 h and 85°C for 5 min. RT-PCR for cyclophilin, gnrh, gfap 
(glial fibrillary acidic protein), gpr54, other target genes expres-
sion was carried out in a Mastercycler (Eppendorf, Germany) in a 
10-μl reaction volume comprising 1× PCR Gold Buffer (Applied 
Biosystems), 2.5 mM MgCl2 (Applied Biosystems), 0.2 mM each 
dNTP (iDNA, Singapore), 0.25 U of AmpliTaq Gold A (Applied 
Biosystems), 0.25 μM each forward and reverse primers (Table S1 
in Supplementary Material), and 1  μl of cDNA sample. PCR 
cycles were carried out under the following conditions: 95°C for 
10 min, 40 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s, 
with a final extension phase of 72°C for 5 min. PCR products were 
electrophoresed on a 2.5% agarose gel, stained with ethidium 
bromide and visualized under an electronic UV transilluminator 
(ATTO, Bio-Instrument, Tokyo, Japan).
statistical analysis
All data are expressed as a mean ± SEM for each group. Statistical 
analysis was carried out using PASW Statistics 18 (IBM SPSS 
Statistics; IBM, Chicago, IL, USA) software. The analysis of live 
cell imaging data was done using two-way repeated measure 
analysis of variance (ANOVA). The analysis of gene expression 
was done using t-test. Difference were considered significant 
when p < 0.05.
resUlTs
Migration of embryonic egFP–gnrh 
neurons in the Brain
The EGFP–GnRH neurons were identified by their fusiform 
morphology in the brain slice preparation of E14 rat brains 
(Figures  1A,B) and maintained in  vitro for up to 36  h for 
time-lapse image analysis. The EGFP–GnRH neurons at E14 
stage exhibited changes in their position (=were migrating) at 
different rates of motility within the brain slice during the 36 h 
of culture condition (Figure 1C). Time-lapse image analysis of 
FigUre 2 | Time-lapse imaging analysis of the enhanced green fluorescent protein (egFP)–gonadotropin-releasing hormone (gnrh) neurons in 
brain tissue cultures from embryonic day 14. Total distance traveled (μm/12 h) (a) and average rate of movement (μm/h) (B) [control, n = 7−10 cells/time point; 
Kisspeptin-10 (Kp-10), n = 7−10 cells/time point] determined across the 36 h culture duration. Data are represented by the mean ± SEM for each group. *p < 0.05 
compared to control group.
FigUre 1 | enhanced green fluorescent protein (egFP)–
gonadotropin-releasing hormone (gnrh) neurons on brain tissue in 
embryonic day 14 (e14) (a). Illustration of E14 rat sagittal head showing 
EGFP–GnRH neurons throughout olfactory bulb and ventral forebrain region 
and highlighted the area for live cell imaging (B). Images of migrating  
EGFP–GnRH neurons in brain tissue culture captured by live cell imaging 
system during 15 h in vitro (c). Scale bar = 50 μm in (a,c).
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the EGFP–GnRH neurons from E14 (n = 6–13 cells/time point) 
were expressed as the total distance traveled (μm/12 h) and the 
average rate of movement (μm/h) at 12 h interval for 36 h dura-
tion (Figure 2). The distance traveled by kisspeptin-10 exposed 
EGFP–GnRH neurons was significantly decreased at the 12-h 
culture time point [control, 158.2  ±  27.5  μm, kisspeptin-10, 
90.0 ± 6.12 μm; t(11) = 2.91; p < 0.05]. After 24 and 36 h of the 
exposure to kisspeptin, the distance traveled by EGFP–GnRH cells 
was same as the control EGFP–GnRH neurons (Figure 2A). The 
average rate of movement of EGFP–GnRH cells was decreased 
in the 12-h culture time point for the exposure to kisspeptin 
[control 13.3 ± 2.3 μm/h, kisspeptin-10 exposed 7.6 ± 0.46 μm/h; 
t(11) = 2.43; p < 0.05]. The EGFP–GnRH neurons from the kiss-
peptin-10 exposed brain slice culture exhibited reduce motility 
compared to the control group maintained in vitro for 12 h. But 
after 24 h and 36 h of the exposure to kisspeptin, the average rate 
of movement of the EGFP–GnRH cells was same as the control 
EGFP–GnRH neurons (Figure 2B).
gPr54 gene Transcripts in embryonic 
egFP–gnrh neurons in the Brain
To determine whether gpr54 gene transcripts are detected in 
embryonic EGFP–GnRH neurons, the expression of gpr54 gene 
in embryonic EGFP–GnRH neurons captured by laser dissection 
was measured using real-time PCR (Figures 3A,B). Gpr54 gene 
and egfp gene transcripts were detected in the laser-captured 
EGFP–GnRH neurons of E14 rat brains (Figure 3C). However, 
gnrh and gnrh receptor gene transcripts were not seen at this 
developmental stage of EGFP–GnRH neurons.
effect of Kisspeptin on apoptosis, cell 
Proliferation, and cytoskeleton-related 
genes expression in embryonic  
egFP–gnrh neurons
To determine whether kisspeptin alter apoptosis, cell prolif-
eration, and cytoskeleton in migrating embryonic EGFP–GnRH 
neurons, levels of apoptosis, cell proliferation, and cytoskeleton-
related gene expression was determined in migrating embryonic 
EGFP–GnRH neurons after 12  h exposure to kisspeptin. 
Apoptosis-related genes, B-cell lymphoma (bcl) 2, glucuronidase, 
Beta (gusB), cysteine-aspartic proteases, or cysteine-dependent 
FigUre 3 | g-protein-coupled receptor 54 (gPr54) mrna expression 
in laser-captured enhanced green fluorescent protein (egFP)–
gonadotropin-releasing hormone (gnrh) neurons in brain tissue 
cultures from embryonic day 14. (a) Photographs of EGFP–GnRH neurons 
in brain tissue culture from embryonic before and (B) after laser capture. Scale 
bar = 50 μm. (c) Composite gel showing amplicons of GnRH (105 bp, lane 2), 
EGFP (179 bp, lane 3), cyclophiline (199 bp, lane 4), GnRH receptor (100 bp, 
lane 5), GPR54 (235 bp, lane 6) in laser-captured microdissected GnRH 
neurons, and non-template controls (NTC, lane 1) Marker, DNA 100-bp ladder.
FigUre 4 | effects of kisspeptin-10 treatment on apoptosis-related 
genes expression in laser-captured egFP–gnrh in brain tissue 
culture from embryonic (e) day 14. Data are presented as the 
mean ± SEM [control: N = 20−25 cells/animals (n = 6), kisspeptin-10 
(Kp-10): N = 20−25 cells/animals (n = 6)]. bcl2, B-cell lymphoma 2; gusB, 
glucuronidase; Beta, caspase 2/9, cysteine-aspartic proteases or 
cysteine-dependent aspartate-directed proteases 2/9.
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aspartate-directed proteases (caspase) 2 and 9 were selected to 
measure the mRNA levels in laser-captured GnRH neurons from 
E14 brain slice culture. There was no difference in the expression of 
these genes between control and exposure to kisspeptin (Figure 4). 
On the other hand, cell proliferation and cytoskeleton-related 
genes, gnrh, tubulin α1 (tα1), prefolding 6 (pfdn), kinetin family 
(kif ), sorting nexin18 (snx) matrix metalloproteinase (mmp)-9, 
doublecortin (dcx), and ankyrin repeat domain-containing protein 
(ankrd) 26 genes were selected to measure their mRNA levels in 
laser-captured GnRH neurons from E14 brain slice culture. There 
was no difference in the level of expression of these genes between 
control and kisspeptin exposed neurons (Figure 5). However, the 
expression of ankrd26 mRNA was upregulated by exposure to 
kisspeptin in laser-captured GnRH neurons from E14 brain slice 
culture [control: 1.0 ± 0.21, kisspeptin: 2.41 ± 0.57; t(11) = −2.34, 
p < 0.05] (Figure 5).
DiscUssiOn
In this study, real-time imaging and capturing of live EGFP–GnRH 
neurons from E14 brain slice cultures facilitated time-lapse analy-
sis and characterization of embryonic GnRH neuronal movement 
following exposure to kisspeptin. Kisspeptin decreased GnRH 
neuronal movement in brain slices and increase ankrd26 gene 
expression in laser-captured GnRH neurons but had no effect on 
apoptosis and cell proliferation-related genes. These data suggest 
that exposure to kisspeptin may inhibit GnRH neuronal move-
ment through novel intracellular ankrd26 signaling.
effects of Kisspeptin on gnrh neuronal 
Movement and gene expression in the Brain
Time-lapse image analysis of rat embryonic E14–GnRH neurons 
between the nasal and brain compartments showed movement of 
GnRH neurons at a velocity of 9–13 μm/h in brain slice cultures 
similar to E13 GnRH neurons in embryonic mouse nasal explants 
culture migrating at a velocity of 12–13 μm/h (38). On the other 
hand, our recent time-lapse imaging study of rat GnRH neurons 
on postnatal day 0 and day 5 showed movement of GnRH 
neurons at a velocity of 3–5 μm/h (39). This suggests that rat 
embryonic GnRH neurons have high motility and, therefore, 
may be a good model to determine intracellular signaling for 
cellular movement. Exposure to kisspeptin reduced the distance 
traveled and velocity of embryonic GnRH neurons after 12  h 
but not after 24 h of treatment. Percentage of GPR54-expressing 
GnRH neurons dramatically is increased during E14.5–16.5 in 
mice (21). This suggests kisspeptin–GPR54 signaling directly 
exerts an acute but transient effect on the movement of GnRH 
neurons during early development. Several inhibitory signal-
ing such as GABA in GnRH migration are identified (14, 40), 
kisspeptin–GPR54 singling may involve in slow down or halt 
GnRH migration for fine-tuning of GnRH development. During 
embryonic stage E14–18, multiple signal transduction pathways 
are engaged to modulate GnRH neuronal movement (38, 41). 
Although the mechanism of kisspeptin–GPR54 in suppressing 
metastasis is still incompletely characterized, previous research 
has shown kisspeptin-10 as an anti-metastatic agent through 
complex cellular signaling including loss of intracellular adhe-
sion, stromal invasion, and attachment at distant sites in several 
types of cancer cells (30, 42–49). A recent study reported that 
kisspeptin-10 affects invasion via modulation of MMP 9 activity 
in breast cancer cells (50). However, kisspeptin-10 does not affect 
the expression of MMP9 gene expression in migrating embryonic 
GnRH neurons in brain slice cultures. Therefore, the effects of 
kisspeptin-10 on migrating GnRH neurons might involve a 
different mechanism. A metastasis-associated protein family 
(MTA) has been identified to promote tumor cell invasion and 
metastasis in human brain glioma (49). Recent evidence proposes 
that GPR54 is expressed in hypoxic areas and endothelial cells of 
tumor blood vessels of glioblastoma (51). Thus, it is possible that 
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FigUre 5 | effects of kisspeptin-10 treatment on cell proliferation and cytoskeleton-related genes expression in laser-captured egFP–gnrh in brain 
tissue culture from embryonic day 14. Data are presented as the mean ± SEM [control, N = 20−25 cells/animals (n = 6); kisspeptin (Kp-10), N = 20−25 cells/
animals (n = 6)]. *p < 0.05 compared between Kisspeptin-10 (1 nM) and control group. gnrh, gonadotropin-releasing hormone; ta1, tubulin a1; kif, kinetin family; 
snx, sorting nexin18; pfdn, prefolding 6; mmp-9, matrix metalloproteinase; dcx, doublecortin; ankrd 26, ankyrin repeat domain-containing protein 26.
kisspeptin-10 may be involved in neuronal or glia specific cellular 
mechanism of metastasis via a novel molecule such as MTA. In 
our study, kisspeptin-10 had no effect on apoptosis genes (bcl 2, 
gusB, caspase 2 and 9) and cell proliferation and cytoskeleton 
related genes (tα1, pfdn6, kif, snx, mmp-9 and dcx) in migrating 
embryonic GnRH neurons. Kisspeptin-10 exposure may affect 
factors related migrating during developmental stage but not 
apoptosis.
effect of Kisspeptin-10 Treatment on 
Ankrd 26 signaling
Kisspeptin-10 treatment increased ankrd 26 mRNA levels and 
inhibited the movement/migration of EGFP–GnRH neurons 
in embryonic brain slice cultures. In our previous study, we 
identified ANKRD protein coding gene expression in laser cap-
ture GnRH neurons from E14 and postnatal day 5 (P5) brains 
through a microarray analysis (52). The levels of ankrd 26 mRNA 
was higher in p5 than, the highly motile and migrating E14 stage 
GnRH neurons. Therefore, cellular ankrd 26 signaling may be 
involved in the anti-migration process in neurons. Ankyrin 
repeat is a key amino acid motif as a scaffold for protein–protein 
interactions (53, 54), thus ankyrin repeat mediated protein–
protein interactions may ultimately help to unravel complex 
cell signaling mechanisms related to the migration process 
in neurons. Interestingly, ankrd 26 gene belongs to the POTE 
family of genes that are highly expressed in the prostate, ovary, 
testis, and placenta of cancer patients (55), which also express 
kisspeptin and GPR54. This suggests that ankrd 26 gene expres-
sion in reproductive organs may be regulated by kisspeption-
GPR54 signaling. Retinoic acid receptor responder (RARRES1) 
is a putative tumor suppressor (56) gene that suppress invasion 
and colony-forming ability of prostate cancer cells (57). Since, 
knockdown of RARRES1 gene upregulates ANKRD 26 protein 
(56), it would be important to see if kisspeptin regulates ankrd 
26 through RARRES1-mediated pathway in neuronal migration. 
ankrd 26 gene expression is reported in the hypothalamus area, 
and it is suggested to involve in obesity and gigantism (58). A lit-
tle knows about the potential physiological functions of ankrd 26 
in the brain during embryonic stage. Further studies are needed 
to understand the direct action of kisspeptin on ankrd 26 gene 
expression and the functions in migrating GnRH neurons.
cOnclUsiOn
In this study, exposure to kisspeptin reduced the movement 
of embryonic EGFP–GnRH neurons in brain slice culture. We 
found that there was no change in the expression of cell prolifera-
tion, cytoskeleton and apoptosis-related genes. However, ankrd 
26 gene in migrating embryonic EGFP–GnRH neurons was 
upregulated by exposure to kisspeptin. These studies support that 
ankrd 26 signaling plays an unidentified role to regulate neuronal 
movement mediated by kisspeptin–GPR54 signaling. Therefore, 
ankrd 26 could be a specific target for elucidating the mechanism 
for suppressing one of pathway in neuronal metastasis by kiss-
peptin–GPR54 signaling. Although kisspeptin–GPR54 system in 
the embryonic brain has only recently been studied, our studies 
suggest that kisspeptin–GPR54 exerts a part of potential function 
on embryonic GnRH development.
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